Cargando…

Mineralocorticoid Receptor Signaling in the Inflammatory Skeletal Muscle Microenvironments of Muscular Dystrophy and Acute Injury

Duchenne muscular dystrophy (DMD) is a striated muscle degenerative disease due to loss of functional dystrophin protein. Loss of dystrophin results in susceptibility of muscle membranes to damage, leading to muscle degeneration and continuous inflammation and fibrosis that further exacerbate pathol...

Descripción completa

Detalles Bibliográficos
Autores principales:	Howard, Zachary M., Gomatam, Chetan K., Piepho, Arden B., Rafael-Fortney, Jill A.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Pharmacology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9273774/ https://www.ncbi.nlm.nih.gov/pubmed/35837290 http://dx.doi.org/10.3389/fphar.2022.942660

Ejemplares similares

Mineralocorticoid receptor antagonists and glucocorticoids differentially affect skeletal muscle inflammation and pathology in muscular dystrophy
por: Howard, Zachary M., et al.
Publicado: (2022)

Mineralocorticoid receptor antagonism by finerenone is sufficient to improve function in preclinical muscular dystrophy
por: Lowe, Jeovanna, et al.
Publicado: (2020)

Mineralocorticoid Receptor Signaling Contributes to Normal Muscle Repair After Acute Injury
por: Hauck, J. Spencer, et al.
Publicado: (2019)

Autophagy in Skeletal Muscle Homeostasis and in Muscular Dystrophies
por: Grumati, Paolo, et al.
Publicado: (2012)

Theragnosis for Duchenne Muscular Dystrophy
por: Luce, Leonela, et al.
Publicado: (2021)

Micro-dystrophin gene therapy demonstrates long-term cardiac efficacy in a severe Duchenne muscular dystrophy model
por: Piepho, Arden B., et al.
Publicado: (2023)

Anti-inflammatory drugs for Duchenne muscular dystrophy: focus on skeletal muscle-releasing factors
por: Miyatake, Shouta, et al.
Publicado: (2016)

Genetic Approaches for the Treatment of Facioscapulohumeral Muscular Dystrophy
por: Lim, Kenji Rowel Q., et al.
Publicado: (2021)

Drug development progress in duchenne muscular dystrophy
por: Deng, Jiexin, et al.
Publicado: (2022)

Muscle Twitch Kinetics Are Dependent on Muscle Group, Disease State, and Age in Duchenne Muscular Dystrophy Mouse Models
por: Peczkowski, Kyra K., et al.
Publicado: (2020)

Corrigendum: Muscle Twitch Kinetics Are Dependent on Muscle Group, Disease State, and Age in Duchenne Muscular Dystrophy Mouse Models
por: Peczkowski, Kyra K., et al.
Publicado: (2022)

Skeletal muscle secretome in Duchenne muscular dystrophy: a pivotal anti-inflammatory role of adiponectin
por: Lecompte, S., et al.
Publicado: (2017)

Prednisolone Attenuates Improvement of Cardiac and Skeletal Contractile Function and Histopathology by Lisinopril and Spironolactone in the mdx Mouse Model of Duchenne Muscular Dystrophy
por: Janssen, Paul M. L., et al.
Publicado: (2014)

Micro-dystrophin gene therapy prevents heart failure in an improved Duchenne muscular dystrophy cardiomyopathy mouse model
por: Howard, Zachary M., et al.
Publicado: (2021)

Modulating fast skeletal muscle contraction protects skeletal muscle in animal models of Duchenne muscular dystrophy
por: Russell, Alan J., et al.
Publicado: (2023)

Skeletal Muscle Metabolism in Duchenne and Becker Muscular Dystrophy—Implications for Therapies
por: Heydemann, Ahlke
Publicado: (2018)

Skeletal muscle regeneration in facioscapulohumeral muscular dystrophy is correlated with pathological severity
por: Banerji, Christopher R S, et al.
Publicado: (2020)

Depletion of skeletal muscle satellite cells attenuates pathology in muscular dystrophy
por: Boyer, Justin G., et al.
Publicado: (2022)

Translating golden retriever muscular dystrophy microarray findings to novel biomarkers for cardiac/skeletal muscle function in Duchenne Muscular Dystrophy
por: Galindo, Cristi L., et al.
Publicado: (2015)

Lessons Learned from Discontinued Clinical Developments in Duchenne Muscular Dystrophy
por: Markati, Theodora, et al.
Publicado: (2021)

The Effect of Deflazacort Treatment on the Functioning of Skeletal Muscle Mitochondria in Duchenne Muscular Dystrophy
por: Dubinin, Mikhail V., et al.
Publicado: (2020)

Bioengineered in vitro skeletal muscles as new tools for muscular dystrophies preclinical studies
por: Fernández-Costa, Juan M., et al.
Publicado: (2021)

Histological Methods to Assess Skeletal Muscle Degeneration and Regeneration in Duchenne Muscular Dystrophy
por: Dubuisson, Nicolas, et al.
Publicado: (2022)

Inflammasome Activity in the Skeletal Muscle and Heart of Rodent Models for Duchenne Muscular Dystrophy
por: Onódi, Zsófia, et al.
Publicado: (2023)

Mineralocorticoid Receptor Antagonists in Diabetic Kidney Disease
por: Kawanami, Daiji, et al.
Publicado: (2021)

Developmental Changes in the ECG of a Hamster Model of Muscular Dystrophy and Heart Failure
por: Hampton, Thomas G., et al.
Publicado: (2012)

Muscle MRI in muscular dystrophies
por: Díaz-Manera, Jordi, et al.
Publicado: (2015)

Metabolic Dysfunction and Altered Mitochondrial Dynamics in the Utrophin-Dystrophin Deficient Mouse Model of Duchenne Muscular Dystrophy
por: Pant, Meghna, et al.
Publicado: (2015)

Chronic Administration of a Leupeptin-Derived Calpain Inhibitor Fails to Ameliorate Severe Muscle Pathology in a Canine Model of Duchenne Muscular Dystrophy
por: Childers, Martin K., et al.
Publicado: (2012)

The Non-Steroidal Mineralocorticoid Receptor Antagonist KBP-5074 Limits Albuminuria and has Improved Therapeutic Index Compared With Eplerenone in a Rat Model With Mineralocorticoid-Induced Renal Injury
por: Jaisser, Frédéric, et al.
Publicado: (2021)

Efficacy of Prednisolone in Generated Myotubes Derived From Fibroblasts of Duchenne Muscular Dystrophy Patients
por: Kameyama, Tsubasa, et al.
Publicado: (2018)

Anti-Remodeling Cardiac Therapy in Patients With Duchenne Muscular Dystrophy, Meta-Analysis Study
por: Raccah, Bruria Hirsh, et al.
Publicado: (2022)

A state-of-the-art review of tamoxifen as a potential therapeutic for duchenne muscular dystrophy
por: Botti, Valeria, et al.
Publicado: (2022)

Comparative proteomic analyses of Duchenne muscular dystrophy and Becker muscular dystrophy muscles: changes contributing to preserve muscle function in Becker muscular dystrophy patients
por: Capitanio, Daniele, et al.
Publicado: (2020)

Anti-Inflammatory and General Glucocorticoid Physiology in Skeletal Muscles Affected by Duchenne Muscular Dystrophy: Exploration of Steroid-Sparing Agents
por: Herbelet, Sandrine, et al.
Publicado: (2020)

Cytokines and Chemokines as Regulators of Skeletal Muscle Inflammation: Presenting the Case of Duchenne Muscular Dystrophy
por: De Paepe, Boel, et al.
Publicado: (2013)

PAX7 target genes are globally repressed in facioscapulohumeral muscular dystrophy skeletal muscle
por: Banerji, Christopher R. S., et al.
Publicado: (2017)

Lamin-Related Congenital Muscular Dystrophy Alters Mechanical Signaling and Skeletal Muscle Growth
por: Owens, Daniel J., et al.
Publicado: (2020)

The skeletal muscle phenotype of the DE50-MD dog model of Duchenne muscular dystrophy
por: Hildyard, John C.W., et al.
Publicado: (2022)

The Angiotensin Converting Enzyme Inhibitor Lisinopril Improves Muscle Histopathology but not Contractile Function in a Mouse Model of Duchenne Muscular Dystrophy
por: Lowe, Jeovanna, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_ov8s666f9becdp5m5qa816t5vm